BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38216080)

  • 1. Long-term Survival After Lung Cancer Resection in the National Lung Screening Trial.
    Potter AL; Senthil P; Keshwani A; McCleery S; Haridas C; Kumar A; Mathey-Andrews C; Martin LW; Yang CJ
    Ann Thorac Surg; 2024 Apr; 117(4):734-742. PubMed ID: 38216080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registry.
    Dziedzic R; Zurek W; Marjanski T; Rudzinski P; Orlowski TM; Sawicka W; Marczyk M; Polanska J; Rzyman W
    Eur J Cardiothorac Surg; 2017 Aug; 52(2):363-369. PubMed ID: 28402455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.
    Cao J; Yuan P; Wang Y; Xu J; Yuan X; Wang Z; Lv W; Hu J
    Ann Thorac Surg; 2018 May; 105(5):1483-1491. PubMed ID: 29462591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of death due to other causes is lower among octogenarians with non-small cell lung cancer after wedge resection than lobectomy/segmentectomy.
    Mimae T; Miyata Y; Yoshimura K; Tsutani Y; Imai K; Ito H; Nakayama H; Ikeda N; Okada M
    Jpn J Clin Oncol; 2021 Oct; 51(10):1561-1569. PubMed ID: 34331062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303.
    Mimae T; Saji H; Nakamura H; Okumura N; Tsuchida M; Sonobe M; Miyazaki T; Aokage K; Nakao M; Haruki T; Okada M; Suzuki K; Chida M
    Ann Surg Oncol; 2021 Nov; 28(12):7219-7227. PubMed ID: 33900499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of lobectomy, segmentectomy, and wedge resection for stage I non-small cell lung cancer.
    Zhang Y; Sun Y; Wang R; Ye T; Zhang Y; Chen H
    J Surg Oncol; 2015 Mar; 111(3):334-40. PubMed ID: 25322915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Segmentectomy versus wedge resection for the treatment of high-risk operable patients with stage I non-small cell lung cancer: a meta-analysis.
    Hou B; Deng XF; Zhou D; Liu QX; Dai JG
    Ther Adv Respir Dis; 2016 Oct; 10(5):435-43. PubMed ID: 27585599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Less is more in solid-dominant lung cancer? Sublobar resection versus lobectomy for solid-dominant stage IA non-small-cell lung cancer: A meta-analysis study.
    Guo J; Liu Y; Tian X; Ren Z; Lin J; Wang B; Liang C
    Mol Clin Oncol; 2019 Nov; 11(5):465-473. PubMed ID: 31620277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
    Saji H; Okada M; Tsuboi M; Nakajima R; Suzuki K; Aokage K; Aoki T; Okami J; Yoshino I; Ito H; Okumura N; Yamaguchi M; Ikeda N; Wakabayashi M; Nakamura K; Fukuda H; Nakamura S; Mitsudomi T; Watanabe SI; Asamura H;
    Lancet; 2022 Apr; 399(10335):1607-1617. PubMed ID: 35461558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival after wedge resection versus lobectomy for stage IA second primary NSCLC with previous lung cancer-directed surgery.
    Song C; Lu Z; Li D; Pan S; Li N; Geng Q
    Front Oncol; 2022; 12():890033. PubMed ID: 36033457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence After Complete Resection for Non-Small Cell Lung Cancer in the National Lung Screening Trial.
    Potter AL; Costantino CL; Suliman RA; Haridas CS; Senthil P; Kumar A; Mayne NR; Panda N; Martin LW; Yang CJ
    Ann Thorac Surg; 2023 Oct; 116(4):684-692. PubMed ID: 37356517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent of Resection Influences Survival in Early-Stage Lung Cancer With Occult Nodal Disease.
    Mynard N; Nasar A; Rahouma M; Lee B; Harrison S; Chow O; Villena-Vargas J; Altorki N; Port J
    Ann Thorac Surg; 2022 Sep; 114(3):959-967. PubMed ID: 35181271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of the surgical approach for patients with cStage IA lung squamous cell carcinoma: A population-based propensity score matching analysis.
    Shao S; Song G; Wang Y; Yi T; Li S; Chen F; Li Y; Liu X; Han B; Liu Y
    Front Oncol; 2022; 12():946800. PubMed ID: 36081555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublobectomy versus lobectomy for stage IA (T1a) non-small-cell lung cancer: a meta-analysis study.
    Liu Y; Huang C; Liu H; Chen Y; Li S
    World J Surg Oncol; 2014 May; 12():138. PubMed ID: 24886396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
    Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
    Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segmentectomy versus lobectomy in the United States: Outcomes after resection for first primary lung cancer and treatment patterns for second primary lung cancers.
    Potter AL; Kim J; McCarthy ML; Senthil P; Mathey-Andrews C; Kumar A; Cao C; Lin MW; Lanuti M; Martin LW; Jeffrey Yang CF
    J Thorac Cardiovasc Surg; 2024 Jan; 167(1):350-364.e17. PubMed ID: 37473997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional survival rate estimates of lobectomy, segmentectomy and wedge resection for stage IA1 non-small cell lung cancer: A population-based study.
    Fan X; Liang Y; Bai Y; Yang C; Xu S
    Oncol Lett; 2020 Aug; 20(2):1607-1618. PubMed ID: 32724402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effectiveness of Lobectomy, Segmentectomy, and Wedge Resection for Pathological Stage I Non-small Cell Lung Cancer in Elderly Patients: A Population-Based Study.
    Zhang X; Lin G; Li J
    Front Surg; 2021; 8():652770. PubMed ID: 33937317
    [No Abstract]   [Full Text] [Related]  

  • 19. Wedge Resection vs Lobectomy for Clinical Stage IA Non-Small Cell Lung Cancer With Occult Lymph Node Disease.
    Kneuertz PJ; Abdel-Rasoul M; D'Souza DM; Moffatt-Bruce SD; Merritt RE
    Ann Thorac Surg; 2023 Jun; 115(6):1344-1351. PubMed ID: 36126718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wedge Resection Versus Segmentectomy for Older Patients With Stage IA Non-Small-Cell Lung Cancer.
    Mathey-Andrews C; Potter AL; Venkateswaran S; Deng JZ; Alvillar AJ; Lin MW; Auchincloss HG; Jeffrey Yang CF
    J Surg Res; 2023 Mar; 283():1133-1144. PubMed ID: 36915005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.